
### [MONDO:0016345](http://purl.obolibrary.org/obo/MONDO_0016345)
**Label:** non-familial restrictive cardiomyopathy

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0008418](http://purl.obolibrary.org/obo/MONDO_0008418) (scleroderma, familial progressive), [MONDO:0019338](http://purl.obolibrary.org/obo/MONDO_0019338) (sarcoidosis), [MONDO:0019564](http://purl.obolibrary.org/obo/MONDO_0019564) (systemic sclerosis), [MONDO:0015691](http://purl.obolibrary.org/obo/MONDO_0015691) (hypereosinophilic syndrome), [MONDO:0017834](http://purl.obolibrary.org/obo/MONDO_0017834) (secondary hypereosinophilic syndrome), 

**Corr. equiv. classes:** [OMIM:612387](http://purl.obolibrary.org/obo/OMIM_612387), [OMIM:181000](http://purl.obolibrary.org/obo/OMIM_181000), [OMIM:612388](http://purl.obolibrary.org/obo/OMIM_612388), [Orphanet:90290](http://www.orpha.net/ORDO/Orphanet_90290), [Orphanet:168956](http://www.orpha.net/ORDO/Orphanet_168956), [Orphanet:90291](http://www.orpha.net/ORDO/Orphanet_90291), [OMIM:254500](http://purl.obolibrary.org/obo/OMIM_254500), [OMIM:181750](http://purl.obolibrary.org/obo/OMIM_181750), [Orphanet:797](http://www.orpha.net/ORDO/Orphanet_797), [Orphanet:85443](http://www.orpha.net/ORDO/Orphanet_85443), [Orphanet:314962](http://www.orpha.net/ORDO/Orphanet_314962), 

**Class expressions from DL-Learner:**

- [HP:0000163](http://purl.obolibrary.org/obo/HP_0000163) (Abnormality of the oral cavity) and [HP:0002206](http://purl.obolibrary.org/obo/HP_0002206) (Pulmonary fibrosis) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 63.64%
- [HP:0000163](http://purl.obolibrary.org/obo/HP_0000163) (Abnormality of the oral cavity) and [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0002206](http://purl.obolibrary.org/obo/HP_0002206) (Pulmonary fibrosis) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 63.64%
- [HP:0000153](http://purl.obolibrary.org/obo/HP_0000153) (Abnormality of the mouth) and [HP:0002206](http://purl.obolibrary.org/obo/HP_0002206) (Pulmonary fibrosis) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 63.64%
- [HP:0000153](http://purl.obolibrary.org/obo/HP_0000153) (Abnormality of the mouth) and [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0002206](http://purl.obolibrary.org/obo/HP_0002206) (Pulmonary fibrosis) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 63.64%
- [HP:0002206](http://purl.obolibrary.org/obo/HP_0002206) (Pulmonary fibrosis) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 56.94%
- [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0002206](http://purl.obolibrary.org/obo/HP_0002206) (Pulmonary fibrosis) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 56.94%
- [HP:0000163](http://purl.obolibrary.org/obo/HP_0000163) (Abnormality of the oral cavity) and [HP:0002206](http://purl.obolibrary.org/obo/HP_0002206) (Pulmonary fibrosis) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 56.94%
- [HP:0000163](http://purl.obolibrary.org/obo/HP_0000163) (Abnormality of the oral cavity) and [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0002206](http://purl.obolibrary.org/obo/HP_0002206) (Pulmonary fibrosis) 56.94%
- [HP:0000153](http://purl.obolibrary.org/obo/HP_0000153) (Abnormality of the mouth) and [HP:0002206](http://purl.obolibrary.org/obo/HP_0002206) (Pulmonary fibrosis) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 56.94%
- [HP:0000153](http://purl.obolibrary.org/obo/HP_0000153) (Abnormality of the mouth) and [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0002206](http://purl.obolibrary.org/obo/HP_0002206) (Pulmonary fibrosis) 56.94%
- [HP:0002206](http://purl.obolibrary.org/obo/HP_0002206) (Pulmonary fibrosis) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 56.94%
- [HP:0002206](http://purl.obolibrary.org/obo/HP_0002206) (Pulmonary fibrosis) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 56.94%
- [HP:0002206](http://purl.obolibrary.org/obo/HP_0002206) (Pulmonary fibrosis) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) 56.94%
- [HP:0002206](http://purl.obolibrary.org/obo/HP_0002206) (Pulmonary fibrosis) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 56.94%
- [HP:0002206](http://purl.obolibrary.org/obo/HP_0002206) (Pulmonary fibrosis) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 56.94%


